We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

LabCorp to Acquire US LABS

By HospiMedica staff writers
Posted on 29 Dec 2004
In a move that will broaden the company's testing services, Laboratory Corporation of America Holdings (LabCorp, Burlington, NC, USA) has agreed to acquire US Pathology Labs, Inc. (US Labs, Irvine, CA, USA) for around U.S.$155 million in cash.

US Labs is a national anatomic pathology reference laboratory devoted to comprehensive high-quality, rapid-response cancer testing. The company provides diagnostic, prognostic, and predictive cancer testing services to hospitals, physicians' offices, and surgery centers. LabCorp is a pioneer in commercializing new diagnostic technologies and was the first in its industry to embrace genomic testing. The company offers more than 4,400 clinical assays, ranging from blood analyses, to HIV and genomic testing.

"The proposed acquisition of US Labs is a key part of LabCorp's efforts to continue to be a leading provider of anatomical pathology services, an important part of our cancer strategy,” noted Tom Mac Mahon, chairman and CEO of LabCorp. "We are also pleased the management team has agreed to continue on in their current responsibilities, as part of LabCorp.”





Related Links:
LabCorp
US Labs

Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Thyroxine ELISA
T4 ELISA

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests